The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Terpigorev S.A.

GU "Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo"

Novikov A.A.

"Research Institute of rheumatology n. a. V. A. Nasonova"

Él' Zeĭn B.A.

Pervyĭ MGMU im. I.M. Sechenova

Aleksandrova E.N.

"Research Institute of rheumatology n. a. V. A. Nasonova"

Iazdovskiĭ V.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Moskalets O.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Paleev F.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Change in the blood cytokine spectrum in patients with pulmonary sarcoidosis

Authors:

Terpigorev S.A., Novikov A.A., Él' Zeĭn B.A., Aleksandrova E.N., Iazdovskiĭ V.V., Moskalets O.V., Paleev F.N.

More about the authors

Journal: Therapeutic Archive. 2013;85(3): 23‑27

Read: 2453 times


To cite this article:

Terpigorev SA, Novikov AA, Él' Zeĭn BA, Aleksandrova EN, Iazdovskiĭ VV, Moskalets OV, Paleev FN. Change in the blood cytokine spectrum in patients with pulmonary sarcoidosis. Therapeutic Archive. 2013;85(3):23‑27. (In Russ.)

Recommended articles:
Cyto­kine status of patients with Alzheimer’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):5-12
Broncho-obstructive diso­rders in sarcoidosis: in search of causes. Journal of Respiratory Medi­cine. 2025;(2):60-65
Myokines — the cardiometabolic risk pote­ntial biomarkers. Russian Journal of Preventive Medi­cine. 2025;(7):119-126
Biomarkers in tear fluid in uveitis. Russian Annals of Ophthalmology. 2025;(4):88-95

References:

  1. Ses' T.P. Osobennosti vospalitel'nogo protsessa pri sarkoidoze legkikh. Tsitokiny i vospalenie 2002; 3: 3-6.
  2. Semenzato G., Adami F., Maschino N., Agostini C. Immune mechanisms in interstitial lung diseases. Allergy 2000; 55: 1103-1120.
  3. Semenzato G., Bortoli M., Brunetta E., Agostini C. Sarcoidosis. Immunology and pathophysiology. Eur Respir Monograph 2005; 32: 49-60.
  4. Agostini C., Semenzato G. Biology and immunology of the granuloma. In: A. Zumla (ed). The granulomatous disorder. Cambridge University press 1999: 3-13.
  5. Elliott D.E. The road from granuloma to fibrosis. In: A. Zumla (ed). The granulomatous disorder. Cambridge University press 1999: 69-74.
  6. Crystal R.G., Bitterman P.B., Mossman B. et al. Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2002; 166: 236-246.
  7. Laurent G., McAnulty R., Hill M., Chambers R. Multiple mechanisms for fibroblast activation in pulmonary fibrosis. Proc Am Thorac Sos 2008; 5: 311-315.
  8. Kingsmore S. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 2006; 5 (4): 310-320.
  9. Novikov A.A., Aleksandrova E.N., Popkova T.V. i dr. Rol' mul'tipleksnogo analiza tsitokinov v otsenke effektivnosti rituksimaba pri lechenii revmatoidnogo artrita. Nauch-prakt revmatol 2011; 3: 51-57.
  10. Katchar K., Eklund A., Grunewald J. Expression of Th1 markers by lung accumulated T cells in pulmonary sarcoidosis. J Intern Med 2003; 254 (6): 564-571.
  11. Miyara M., Amoura Z., Parizot C. et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 2006; 203 (2): 359-370.
  12. Hashimoto S., Nakayama T., Gon Y. et al. Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1 alpha (MIP-1 alpha) levels with disease activity and clinical course of sarcoidosis. Clin Exp Immunol 1998; 111: 604-610.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.